India can be a real alternative to China in pharmaceuticals
Gopal Nadadur is based in New Delhi as vice president for South Asia at The Asia Group, a strategic advisory firm. Sam Ide is based in Washington as the firm's vice president for China.
The COVID pandemic was a wake-up call for many governments about the public health and national security risks of overreliance on a narrow set of partner countries for pharmaceuticals, medical technologies and other health care products.